An open-label, parallel-group, randomized, multicenter study to assess the safety and efficacy of vilaprisan (BAY 1002670) in subjects with uterine fibroids versus standard of care (Protocol # 16953)
The study is performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care